1.
J Med Chem
; 57(18): 7550-64, 2014 Sep 25.
Artículo
en Inglés
| MEDLINE
| ID: mdl-25101488
RESUMEN
High-affinity, functionally potent, urea-based antagonists of CCR1 have been discovered. Modulation of PXR transactivation has revealed the selective and orally bioavailable CCR1 antagonist BMS-817399 (29), which entered clinical trials for the treatment of rheumatoid arthritis.